广东省医疗机构2011-2013年销售金额排序前20位药品应用分析

发布时间：2019-06-12 09:22

【摘要】：目的:为促进医疗机构合理用药提供参考。方法:采用回顾性方法,对广东省医疗机构2011-2013年销售金额排序前20位药品的销售金额、用药频度(DDDs)、日均费用(DDC)等进行统计、分析。其中,2011、2012、2013年分别统计101、112、117家医疗机构。结果:销售金额居首位的是前列地尔注射液或阿托伐他汀钙片;销售金额排序居前5位的药物类别有心血管系统药、抗肿瘤药、抗感染药及影响免疫功能药;合资药品的销售金额始终占较大比例;DDDs排序列前4位的均是心血管系统药,DDC排序前6位的是抗肿瘤药、影响免疫功能药和抗感染药。结论:广东省医疗机构药品销售金额呈明显的增长趋势;医院管理应当重点关注当地疾病谱的变化,以促进药物有效、经济、合理地使用。
[Abstract]:Objective: to provide reference for promoting rational drug use in medical institutions. Methods: the sales amount of the top 20 drugs in Guangdong medical institutions from 2011 to 2013 was counted and analyzed by retrospective method, such as the average daily cost of (DDDs), and the average cost of drug use in Guangdong medical institutions from 2011 to 2013. methods: the sales amount of the top 20 drugs in Guangdong medical institutions from 2011 to 2013 were counted and analyzed. Among them, 2011, 2012, 2013 respectively counted 101112117 medical institutions. Results: alprostadil injection or Atto statin calcium tablets ranked first in sales amount; cardiovascular system drugs, antitumor drugs, anti-infective drugs and drugs affecting immune function were the top five drugs in the order of sales amount; the sales amount of joint venture drugs always accounted for a large proportion; the top four in DDDs sequence were cardiovascular drugs, and the top 6 drugs in DDC ranking were antineoplastic drugs, anti-infective drugs and anti-infective drugs. Conclusion: the amount of drug sales in medical institutions in Guangdong Province shows an obvious increasing trend, and hospital management should pay attention to the changes of local disease spectrum in order to promote the effective, economical and rational use of drugs.
【作者单位】：中山大学附属第三医院药剂科;
【分类号】：R95

【参考文献】